CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

December 15, 2021

Study Completion Date

September 25, 2022

Conditions
WartsWarts HandVerruca
Interventions
DEVICE

CellFX System Device

The CellFX System utilizes non-thermal, localized delivery of a timed series of low energy, nanosecond electrical pulses that can trigger regulated cell death.

DEVICE

Cryosurgery Liquid Nitrogen Sprayer

Cryosurgery will be standardized across all investigational sites using the Brymill Cry-Ac spray canister with standard cryoprobe.

Trial Locations (10)

10022

Juva Skin & Laser Center, New York

28207

Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte

29414

Dermatology & Laser Center of Charleston, Charleston

34685

Palm Harbor Dermatology, Clearwater

60435

Oak Dermatology, Joliet

77056

Austin Institute for Clinical Research, Inc., Houston

78550

Austin Institute for Clinical Research, Inc., Pflugerville

80111

AboutSkin Dermatology and DermSurgery, Greenwood Village

85255

Investigate MD, Scottsdale

90210

Moy-Fincher-Chipps Dermatology, Beverly Hills

All Listed Sponsors
lead

Pulse Biosciences, Inc.

INDUSTRY

NCT04738734 - CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts | Biotech Hunter | Biotech Hunter